WILMINGTON, MA, –Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that additional Quantum Sniffer QS-H150s have been sold in the United States, Singapore, and Indonesia.

The majority of these systems will be used for corporate security, a growing market segment for Implant Sciences. A large U.S. corporate customer is deploying the QS-H150 to protect its personnel and assets in the wake of bomb threats at one of its facilities. In Southeast Asia, Quantum Sniffers will be used to increase security at a liquefied natural gas facility.

“Implant Sciences has recently recorded a number of sales to corporations. Corporate buyers are looking for equipment that delivers high performance with a low total cost of ownership and operation — just what Implant Sciences’ products have been doing for years,” stated Glenn D. Bolduc, Implant Sciences President and CEO. “We believe the QS-B220’s ability to deliver similar results for both explosives and narcotics detection will provide Implant Sciences with significant opportunities in the future in corporate security, passenger screening, and air cargo applications.”

About the Quantum Sniffer(TM) QS-H150

The QS-H150 is a handheld explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-H150 uses no radioactive materials and features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.

About the Quantum Sniffer(TM) QS-B220

The QS-B220, introduced in May 2011, is a benchtop explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, plus narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences’ QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company’s QS-B220 benchtop explosives and narcotics trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.